ERC Proof of Concept grant for three groups UMC Utrecht

The teams of three principal investigators at UMC Utrecht have received a prestigious ERC Proof of Concept grant. They are the groups of Hester den Ruijter, Ynte Ruigrok and Joost Sluijter. The funding will enable them to bring their scientific discoveries one step closer to application in practice.
The ERC Proof of Concept grant is a grant from the European Research Council (ERC) intended to support researchers in translating fundamental research into practical applications. The goal is to further develop promising research results and bring them closer to use in society, for example through prototypes, patents or collaborations with industry. Thanks to the awarded funding, the three research teams can further develop their innovative ideas. The following projects are involved:
Coronary heart disease early detection
Hester den Ruijter and her team are focusing on the development of an innovative blood test that helps in the early detection of coronary heart disease in both men and women. This application was co-authored by Tim Sakkers, who also plays a key role in the research. Coronary heart disease is often recognized too late in women because the symptoms and development are different than in men. This blood test uses DNA signals (cell-free DNA methylation biomarkers) secreted by calcified arteries (atherosclerotic plaques). This allows doctors to understand the state of the plaque and account for male-female differences. The test, which is affordable and easy to use, has the potential to be widely used in primary care without the need for a hospital visit.
Brain bleeding non-invasively prevented
Ynte Ruigrock’s team is focused on finding a non-invasive treatment for brain aneurysms to prevent fatal brain hemorrhages. PhD student Jos Kanning, co-supervised by associate professor Mirjam Geerlings of Amsterdam UMC and associate professor Shahab Abtahi of Utrecht University, has been instrumental in identifying five commonly prescribed drugs associated with a reduced risk of aneurysm-induced brain bleeding: lisinopril, amlodipine, tamsulosin, simvastatin and metformin. These drugs act on a specific molecular process, the TGF-β pathway, which plays an important role in vascular disease. The study combines genetic and epidemiological data to confirm the drugs’ actions and also looks at differences between men and women. The ultimate goal is to develop a safe and affordable treatment that can prevent bleeding from aneurysms, as an alternative to invasive surgery.
Delivering drugs better into the body
Joost Sluijter ’s team will explore a promising new way to deliver drugs into the body, using extracellular vesicles. These microscopic “packets” naturally transport substances between cells and have unique advantages over traditional methods. Using virus-like, smart proteins that self-assemble, the team is working on a more precise and effective system to deliver drugs exactly to the right place in the body. University lecturer Zhiyong Lei, postdoc Nazma Ilahibaks and PhD student Songpu Xie are each major contributors to this project. The goal? To develop a manufacturing process that not only works, but is also affordable and scalable.
About the ERC
The European Research Council (ERC) is Europe’s leading funding organization for innovative scientific research. An independent governing body, the Scientific Council, leads the organization. With its complementary Proof of Concept grant scheme, the ERC helps European scientists bridge the gap between groundbreaking research and the early stages of its commercialization. These projects have the potential to bring about real change in healthcare and science.

Design and start of construction for new greenhouses at the Botanical Gardens announced
The design for the new greenhouse complex of the Botanical Gardens has been finalized, the construction partners have been selected and preparations for construction will start in November 2026. This brings the realization of the new complex one step closer. Construction is scheduled for spring 2027.

Senior civil servants from the Ministries of Economic Affairs and Climate Policy (EZK) and Health, Welfare and Sport (VWS) visit Utrecht Science Park to exchange knowledge on improving prevention, healthcare and economic earning capacity.
How can we ensure that innovations reach patients more effectively and quickly, while also contributing to the Netherlands’ future earning capacity? This question was at the heart of a visit by senior civil servants from the Ministry of Economic Affairs and Climate Policy and the Ministry of Health, Welfare and Sport to Utrecht Science Park on Friday, 30 October.

2.5-hectare new nature reserve at Utrecht Science Park opened
In an area where education, healthcare, housing and research compete for space, 2.5 hectares – equivalent to seven football pitches – of new nature has been created. A 1.6-kilometre-long ‘green corridor’ connects Utrecht Science Park with the surrounding nature reserves, enhances biodiversity and makes the area more attractive to plants and animals.

His Majesty the King visits large-scale exercise at the Major Incident Hospital at Utrecht Science Park: prepared together for major emergencies
On Saturday, October 31, a large-scale exercise took place at the Major Incident Hospital at the Utrecht Science Park. During the exercise, dubbed “Dubbelspoor” (Dual Track), the Major Incident Hospital had to respond to two major incidents almost simultaneously. In Amersfoort, a train carrying thirty injured Dutch military personnel arrived. At nearly the same time, a coach plowed into a crowd during a Halloween celebration. His Majesty the King also visited both locations, marking the 35th anniversary of the Major Incident Hospital.